Crinetics Pharmaceuticals (CRNX) Cash from Investing Activities (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Cash from Investing Activities came in at -$252.4 million in Q1 2026, down 193.57% year-on-year from $269.7 million in Q1 2025, and down 541.91% quarter-over-quarter from $57.1 million in Q4 2025.
Crinetics Pharmaceuticals has reported Cash from Investing Activities for 10 years, with the latest figure at -$252.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 193.57% year-over-year to -$252.4 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (up 101.14% YoY), and the FY2025 full-year result was $173.9 million, up 130.25% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$252.4 million, down from $57.1 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $164.8 million in Q3 2025, with the low at -$542.1 million in Q4 2024.
- Average Cash from Investing Activities over 5 years is -$60.5 million, with a median of $309000.0 recorded in 2024.
- Peak annual rise in Cash from Investing Activities reached 699.93% in 2025, while the deepest fall reached 27919.09% in 2025.
- Tracing CRNX's Cash from Investing Activities over 5 years: stood at $36.9 million in 2022, then slumped by 336.91% to -$87.3 million in 2023, then tumbled by 520.89% to -$542.1 million in 2024, then soared by 110.53% to $57.1 million in 2025, then slumped by 541.91% to -$252.4 million in 2026.
- The last three Cash from Investing Activities figures came in at -$252.4 million (Q1 2026), $57.1 million (Q4 2025), and $164.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -252.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -252.36 Mn |
| Mar 31, 2026 | -252.36 Mn |
| Dec 31, 2025 | 57.11 Mn |
| Dec 31, 2025 | 57.11 Mn |
| Sep 30, 2025 | 164.81 Mn |
| Sep 30, 2025 | 164.81 Mn |
| Jun 30, 2025 | 37.95 Mn |
| Jun 30, 2025 | 37.95 Mn |
| Mar 31, 2025 | -85.96 Mn |
| Mar 31, 2025 | -85.96 Mn |
| Dec 31, 2024 | -542.09 Mn |
| Dec 31, 2024 | -542.09 Mn |
| Sep 30, 2024 | 20.60 Mn |
| Sep 30, 2024 | 20.60 Mn |
| Jun 30, 2024 | -53.64 Mn |
| Jun 30, 2024 | -53.64 Mn |
| Mar 31, 2024 | 309,000.00 |
| Mar 31, 2024 | 309,000.00 |
| Dec 31, 2023 | -87.31 Mn |
| Dec 31, 2023 | -87.31 Mn |
| Sep 30, 2023 | -193.30 Mn |
| Sep 30, 2023 | -193.30 Mn |
| Jun 30, 2023 | 31.44 Mn |
| Jun 30, 2023 | 31.44 Mn |
| Mar 31, 2023 | 48.76 Mn |
| Mar 31, 2023 | 48.76 Mn |
| Dec 31, 2022 | 36.85 Mn |
| Dec 31, 2022 | 36.85 Mn |
| Sep 30, 2022 | 6.82 Mn |
| Sep 30, 2022 | 6.82 Mn |
| Jun 30, 2022 | -174.27 Mn |
| Jun 30, 2022 | -174.27 Mn |
| Mar 31, 2022 | -43.38 Mn |
| Mar 31, 2022 | -43.38 Mn |
| Dec 31, 2021 | -101.80 Mn |
| Dec 31, 2021 | -101.80 Mn |
| Sep 30, 2021 | -7.03 Mn |
| Sep 30, 2021 | -7.03 Mn |
| Jun 30, 2021 | 19.84 Mn |
| Jun 30, 2021 | 19.84 Mn |
| Mar 31, 2021 | 32.50 Mn |
| Mar 31, 2021 | 32.50 Mn |
| Dec 31, 2020 | -8.89 Mn |
| Dec 31, 2020 | -8.89 Mn |
| Sep 30, 2020 | -24.83 Mn |
| Sep 30, 2020 | -24.83 Mn |
| Jun 30, 2020 | 17.60 Mn |
| Jun 30, 2020 | 17.60 Mn |
| Mar 31, 2020 | 16.34 Mn |
| Mar 31, 2020 | 16.34 Mn |
| Dec 31, 2019 | -12.82 Mn |
| Dec 31, 2019 | -12.82 Mn |
| Sep 30, 2019 | 20.45 Mn |
| Sep 30, 2019 | 20.45 Mn |
| Jun 30, 2019 | 9.44 Mn |
| Jun 30, 2019 | 9.44 Mn |
| Mar 31, 2019 | 24.60 Mn |
| Mar 31, 2019 | 24.60 Mn |
| Dec 31, 2018 | -118.68 Mn |
| Dec 31, 2018 | -118.68 Mn |
| Sep 30, 2018 | -251,000.00 |
| Sep 30, 2018 | -251,000.00 |
| Jun 30, 2018 | -469,000.00 |
| Jun 30, 2018 | -469,000.00 |
| Mar 31, 2018 | -57,000.00 |
| Mar 31, 2018 | -57,000.00 |
| Dec 31, 2017 | -231,000.00 |
| Dec 31, 2017 | -231,000.00 |
| Sep 30, 2017 | -18,000.00 |
| Sep 30, 2017 | -18,000.00 |